These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22993019)

  • 1. [New oral anticoagulants in the prevention of embolic complications in patients with atrial fibrillation. Polish Cardiac Society, Polish Neurological Society and Working Group on Haemostasis of the Polish Society of Haematologists and Transfusiologists consensus statement].
    Pruszczyk P; Stępińska J; Banasiak W; Członkowska A; Opolski G; Niewada M; Ponikowski P; Tendera M; Windyga J
    Kardiol Pol; 2012; 70(9):979-88. PubMed ID: 22993019
    [No Abstract]   [Full Text] [Related]  

  • 2. A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation.
    Wisler JW; Becker RC
    Crit Pathw Cardiol; 2012 Jun; 11(2):55-61. PubMed ID: 22595815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive treatment of systemic embolic complications of atrial fibrillation].
    Asseman P; Bauchart JJ; Amrouni N; Lesenne M; Neuville C; Loubeyre C; Elkohen M; Thery C; Jude B
    Ann Cardiol Angeiol (Paris); 1992 Mar; 41(3):163-9. PubMed ID: 1610098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.
    ROCKET AF Study Investigators
    Am Heart J; 2010 Mar; 159(3):340-347.e1. PubMed ID: 20211293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification.
    Cabral KP; Ansell J; Hylek EM
    J Thromb Haemost; 2011 Mar; 9(3):441-9. PubMed ID: 21176102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prevention in atrial fibrillation: current status and near-future directions.
    De Caterina R; Hylek EM
    Am J Med; 2011 Sep; 124(9):793-9. PubMed ID: 21745652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation and embolic complications.
    Maru M
    East Afr Med J; 1997 Jan; 74(1):3-5. PubMed ID: 9145567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.
    Morales-Vidal S; Schneck MJ; Flaster M; Biller J
    Expert Rev Neurother; 2012 Feb; 12(2):179-89; quiz 190. PubMed ID: 22288673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Embolic complications in atrial fibrillation. Data of the Studio Italiano Fibrillation Atriale (SIFA)].
    G Chir; 1995 Mar; 16(3):137-9. PubMed ID: 7547128
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.
    Schirmer SH; Baumhäkel M; Neuberger HR; Hohnloser SH; van Gelder IC; Lip GY; Böhm M
    J Am Coll Cardiol; 2010 Dec; 56(25):2067-76. PubMed ID: 21144965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embolic events in 93 elderly Chinese patients with atrial fibrillation.
    Cao X; Wang S; Jiang L; Liu L; Huang H; Lu Z
    Chin Med J (Engl); 2000 Apr; 113(4):320-3. PubMed ID: 11775227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
    Uchiyama S; Ibayashi S; Matsumoto M; Nagao T; Nagata K; Nakagawara J; Tanahashi N; Tanaka K; Toyoda K; Yasaka M
    J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):165-73. PubMed ID: 22440950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anticoagulants for non-valvular atrial fibrillation.
    Xu B; Whitbourn R
    Heart Lung Circ; 2012 Aug; 21(8):463-7. PubMed ID: 22542860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expanded arsenal in atrial fibrillation: bye-bye marcumar?].
    MMW Fortschr Med; 2012 Jan; 154(1):20. PubMed ID: 22641998
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of embolism due to chronic auricular fibrillation with persantin (dipyridamole) combined with aspirin].
    Han ZX; Ma GY; Ma CM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):250. PubMed ID: 17448289
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin.
    Harenberg J; Weuster B; Pfitzer M; Dempfle CE; Stehle G; Kübler W; Schlierf G
    Semin Thromb Hemost; 1993; 19 Suppl 1():116-21. PubMed ID: 8395713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?].
    Calvo Romero JM
    Rev Clin Esp; 2011 Mar; 211(3):142-6. PubMed ID: 21371701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dabigatran, a new oral anticoagulant].
    Uchiyama S
    Brain Nerve; 2011 Apr; 63(4):411-5. PubMed ID: 21441645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is the warfarin era over?].
    Reikvam Å
    Tidsskr Nor Laegeforen; 2012 Dec; 132(23-24):2583. PubMed ID: 23338065
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atrial fibrillation. What's new in treatment and prophylaxis of embolic complications?].
    Musiał WJ
    Pol Merkur Lekarski; 1996 Nov; 1(5):351-4. PubMed ID: 9273217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.